Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Anna Celotti, Franco Gargiulo, Eugenia Quiros-Roldan, Martina Properzi, Maria Antonia De Francesco, Davide Coletto, Francesca Caccuri, Ilaria Izzo, Arnaldo Caruso, Francesco Castelli & Emanuele Focà. (2020) Presence of V72I, G123S and R127K Integrase Inhibitor polymorphisms could reduce ART effectiveness: a retrospective longitudinal study. HIV Research & Clinical Practice 21:1, pages 24-33.
Read now
Read now
M. Sayan, A. Gündüz, G. Ersöz, A. İnan, A. Deveci, G. Özgür, F. Sargın, G. Karagöz, A. İnci, D. İnan, A Ülçay, İ. Karaoğlan, S. Kaya, S.S. Kutlu, K. Süer, A. Çağatay & H. Akalın. (2016) Integrase Strand Transfer Inhibitors (INSTIs) Resistance Mutations in HIV-1 Infected Turkish Patients. HIV Clinical Trials 17:3, pages 109-113.
Read now
Read now
Jose Luis Blanco Arévalo & Gary George Whitlock. (2014)
Dolutegravir: an exciting new kid on the block. Expert Opinion on Pharmacotherapy 15:4, pages 573-582.
Read now
Read now
James Nuttall, Tammy Meyers & Brian Eley. (2013) Clinical utility of raltegravir for the treatment of HIV infection in children and adolescents. Pediatric Health, Medicine and Therapeutics 4, pages 75-87.
Read now
Read now
Articles from other publishers (13)
Djeneba B. Fofana, Houdou Diarra, Ibrahima Guindo, Mahamadou K. Savadogo, Marceline d’Almeida, Fatoumata I. Diallo, Aliou Baldé, Cathia Soulié, Amadou Kone, Anne-Geneviève Marcelin, Almoustapha I. Maiga, Sidonie Lambert-Niclot, Mamoudou Maiga, Sally McFall, Claudia A. Hawkins, Robert L. Murphy, Mariam Sylla, Christine Katlama, Jane L. Holl, Vincent Calvez & Laurence Morand-Joubert. (2023) Prevalence of HIV-1 Natural Polymorphisms and Integrase-Resistance-Associated Mutations in African Children. Viruses 15:2, pages 546.
Crossref
Crossref
Wassim Chehadeh, Osama Albaksami & Shaikhah Al-Shammari. (2020) Virologic failure after 48 weeks of raltegravir-based regimen in low HIV-1 incidence setting. Antiviral Chemistry and Chemotherapy 28, pages 204020662092790.
Crossref
Crossref
Ya-Wei Weng, I-Tzu Chen, Hung-Chin Tsai, Kuan-Sheng Wu, Yu-Ting Tseng, Cheng-Len Sy, Jui-Kuang Chen, Susan Shin-Jung Lee & Yao-Shen Chen. (2019) Trend of HIV transmitted drug resistance before and after implementation of HAART regimen restriction in the treatment of HIV-1 infected patients in southern Taiwan. BMC Infectious Diseases 19:1.
Crossref
Crossref
Belén Alejos, Inés Suárez-García, Otilia Bisbal, José Antonio Iribarren, Víctor Asensi, Miguel Górgolas, Roberto Muga, Santiago Moreno & Inma Jarrín. (2019) Choice of the initial antiretroviral treatment for HIV-positive individuals in the era of integrase inhibitors. PLOS ONE 14:8, pages e0221598.
Crossref
Crossref
Véronique Joly, Charles Burdet, Roland Landman, Marie Vigan, Charlotte Charpentier, Christine Katlama, André Cabié, Aida Benalycherif, Gilles Peytavin, Patrick Yeni, France Mentre, Anne-Laure Argoud, Imane Amri, Diane Descamps, Yazdan Yazdanpanah, Cécile Goujard, Véronique Joly, Bao Phung, Jean Paul Viard, Laurence Weiss, Claudine Duvivier, Christine Katlama, Pierre Marie Girard, Jean Michel Molina, Philippe Morlat, Christine Jacomet, Lionel Piroth, André Cabié, Isabelle Poizot-Martin, Jacques Reynes, Clotilde Allavena, Eric Billaud, David Boutouille, François Raffi, Véronique Reliquet, Eric Roenthal, Alissa Naqvi, Hughes Aumaitre, Faouzi Souala, Louis Bernard, Noemie Biezunski, Faiza Ajana, Patrick Miailhes, Karine Amat, Aida Benalicherif & Babacar Sylla. (2019) Dolutegravir and lamivudine maintenance therapy in HIV-1 virologically suppressed patients: results of the ANRS 167 trial (LAMIDOL). Journal of Antimicrobial Chemotherapy 74:3, pages 739-745.
Crossref
Crossref
S Modica, B Rossetti, F Lombardi, F Lagi, M Maffeo, R D'Autilia, M Pecorari, I Vicenti, B Bruzzone, G Magnani, S Paolucci, D Francisci, G Penco, D Sacchini, M Zazzi, A De Luca & A Di Biagio. (2019) Prevalence and determinants of resistance mutations in HIV-1-infected patients exposed to integrase inhibitors in a large Italian cohort. HIV Medicine 20:2, pages 137-146.
Crossref
Crossref
Maria Antonia De FrancescoIlaria IzzoMartina ProperziFranco GargiuloFrancesca CaccuriEugenia Quiros-RoldanFrancesco CastelliArnaldo CarusoEmanuele Focà. (2018) Prevalence of Integrase Strand Transfer Inhibitors Resistance Mutations in Integrase Strand Transfer Inhibitors-Naive and -Experienced HIV-1 Infected Patients: A Single Center Experience. AIDS Research and Human Retroviruses 34:7, pages 570-574.
Crossref
Crossref
Miłosz Parczewski, Magdalena Leszczyszyn-Pynka & Anna Urbańska. (2017) Differences in the integrase and reverse transcriptase transmitted resistance patterns in Northern Poland. Infection, Genetics and Evolution 49, pages 122-129.
Crossref
Crossref
Michael E. Abram, Renee R. Ram, Nicolas A. Margot, Tiffany L. Barnes, Kirsten L. White, Christian Callebaut & Michael D. Miller. (2017) Lack of impact of pre-existing T97A HIV-1 integrase mutation on integrase strand transfer inhibitor resistance and treatment outcome. PLOS ONE 12:2, pages e0172206.
Crossref
Crossref
Jodie D'Costa, Megan Gooey, Nicole Richards, Rizmina Sameer, Elaine Lee & Doris Chibo. (2017) Analysis of transmitted HIV drug resistance from 2005 to 2015 in Victoria, Australia: a comparison of the old and the new. Sexual Health 14:6, pages 558.
Crossref
Crossref
Teresa Llácer Delicado, Esther Torrecilla & África Holguín. (2016) Deep analysis of HIV-1 natural variability across HIV-1 variants at residues associated with integrase inhibitor (INI) resistance in INI-naive individuals. Journal of Antimicrobial Chemotherapy 71:2, pages 362-366.
Crossref
Crossref
Joanne D Stekler, Jennifer McKernan, Ross Milne, Kenneth A Tapia, Kateryna Mykhalchenko, Sarah Holte, Janine Maenza, Claire E Stevens, Susan E Buskin, James I Mullins, Lisa M Frenkel & Ann C Collier. (2015) Lack of Resistance to Integrase Inhibitors among Antiretroviral-Naive Subjects with Primary HIV-1 Infection, 2007–2013. Antiviral Therapy 20:1, pages 77-80.
Crossref
Crossref
Olga Shadrina, Olga Krotova, Julia Agapkina, Ekaterina Knyazhanskaya, Sergey Korolev, Elizaveta Starodubova, Alecia Viklund, Vladimir Lukashov, Mauro Magnani, Patrik Medstrand, Vadim Karpov, Marina Gottikh & Maria Isaguliants. (2014) Consensus HIV-1 subtype A integrase and its raltegravir-resistant variants: Design and characterization of the enzymatic properties. Biochimie 102, pages 92-101.
Crossref
Crossref